Publications
See a complete PubMed list of publications by Sergei Grivennikov, PhD.
Selected Key Publications
- Andreeva NV, Gabbasova RR, Grivennikov SI. Microbiome in cancer progression and therapy. Curr Opin Microbiol. 2020 Aug;56:118-126.
- Greten FR*, Grivennikov SI.* Inflammation and cancer: triggers, mechanisms and consequences. Immunity. 2019 Jul 16;51(1):27-41. *equal senior contribution
- Dmitrieva-Posocco OS, Dzutsev A, Posocco D, Hou V, Yuan W, Thovarai V, Mufazalov IA, Gunzer M, Shilovskyi IP, Khaitov MR, Trinchieri G, Waisman A, Grivennikov SI. Cell-type-specific responses to interleukin-1 control microbial invasion and tumor-elicited inflammation in colorectal cancer. Immunity. 2019 Jan 15;50(1):166-180.e7.
- Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY, Kossenkov AV, Hazen SL, Trinchieri G, Grivennikov SI*, Koltsova EK*. An Interleukin-23-Interleukin-22 axis regulates intestinal microbial homeostasis to protect from diet-induced atherosclerosis. Immunity. 2018 Nov 20;49(5):943-957.E9. *equal senior contribution
- Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013 Mar;35(2):229-244.
- Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012; 491(7423):254-258.
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation and cancer. Cell. 2010 Mar 19;140(6):883-899.
Contact the Grivennikov Lab
8700 Beverly Blvd.
Davis Building, Suites 2094D & E
Los Angeles, CA 90048